PNU-120,596: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
== PNU-120,596 == | |||
[[File:PNU-120596.svg|thumb|right|Chemical structure of PNU-120,596]] | |||
PNU-120,596 | |||
'''PNU-120,596''' is a chemical compound that acts as a positive allosteric modulator of the [[_7 nicotinic acetylcholine receptor]]. It is primarily used in scientific research to study the function and pharmacology of this receptor subtype. | |||
PNU-120,596 acts as a positive allosteric modulator | |||
== | === Mechanism of Action === | ||
PNU-120,596 | PNU-120,596 enhances the activity of the [[_7 nicotinic acetylcholine receptor]] by binding to an allosteric site distinct from the acetylcholine binding site. This modulation increases the receptor's response to its natural ligand, [[acetylcholine]], leading to enhanced ion flow through the receptor's ion channel. | ||
== | === Pharmacological Effects === | ||
The compound has been shown to improve cognitive function in animal models, suggesting potential therapeutic applications in [[neurological disorders]] such as [[Alzheimer's disease]] and [[schizophrenia]]. By potentiating the _7 receptor, PNU-120,596 may enhance synaptic plasticity and neuroprotection. | |||
== | === Research Applications === | ||
PNU-120,596 is widely used in [[neuroscience]] research to explore the role of _7 nicotinic receptors in the [[central nervous system]]. It helps in understanding the receptor's involvement in [[cognitive processes]], [[memory]], and [[learning]]. | |||
=== Safety and Toxicology === | |||
As a research chemical, PNU-120,596 is not approved for human use. Studies in animals have been conducted to assess its safety profile, but comprehensive toxicological data are limited. | |||
== Related Pages == | |||
* [[Nicotinic acetylcholine receptor]] | * [[Nicotinic acetylcholine receptor]] | ||
* [[ | * [[Allosteric modulation]] | ||
* [[Cognitive enhancers]] | |||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
[[Category: | [[Category:Nicotinic agonists]] | ||
Latest revision as of 04:03, 13 February 2025
PNU-120,596[edit]

PNU-120,596 is a chemical compound that acts as a positive allosteric modulator of the _7 nicotinic acetylcholine receptor. It is primarily used in scientific research to study the function and pharmacology of this receptor subtype.
Mechanism of Action[edit]
PNU-120,596 enhances the activity of the _7 nicotinic acetylcholine receptor by binding to an allosteric site distinct from the acetylcholine binding site. This modulation increases the receptor's response to its natural ligand, acetylcholine, leading to enhanced ion flow through the receptor's ion channel.
Pharmacological Effects[edit]
The compound has been shown to improve cognitive function in animal models, suggesting potential therapeutic applications in neurological disorders such as Alzheimer's disease and schizophrenia. By potentiating the _7 receptor, PNU-120,596 may enhance synaptic plasticity and neuroprotection.
Research Applications[edit]
PNU-120,596 is widely used in neuroscience research to explore the role of _7 nicotinic receptors in the central nervous system. It helps in understanding the receptor's involvement in cognitive processes, memory, and learning.
Safety and Toxicology[edit]
As a research chemical, PNU-120,596 is not approved for human use. Studies in animals have been conducted to assess its safety profile, but comprehensive toxicological data are limited.